← Browse by Condition
Medical Condition
neuroblastoma
Total Trials
13
Recruiting Now
13
Trial Phases
Phase 2, Phase 1, Phase 1, Phase 2
ClinicalMetric tracks all active clinical trials for neuroblastoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — neuroblastoma Clinical Trials
How many clinical trials are currently recruiting for neuroblastoma?
ClinicalMetric currently tracks 13 actively recruiting clinical trials for neuroblastoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 13. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for neuroblastoma?
neuroblastoma research spans Phase 1 (7 trials), Phase 2 (6 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a neuroblastoma clinical trial?
Eligibility criteria for neuroblastoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 7
Phase 2 6
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06638931 Phase 2
Recruiting
Enrollment
28 pts
Location
Brazil
Sponsor
Instituto do Cancer do Estado ...
NCT02508038 Phase 1
Recruiting
Enrollment
22 pts
Location
United States
Sponsor
University of Wisconsin, Madis...
NCT06013618 Phase 2
Recruiting
Enrollment
120 pts
Location
China
Sponsor
Sun Yat-Sen University Cancer ...
NCT07195500
Recruiting
Enrollment
30 pts
Location
China
Sponsor
Nanjing First Hospital, Nanjin...
NCT05701306 Phase 1, Phase 2
Recruiting
Enrollment
100 pts
Location
China
Sponsor
Ascentage Pharma Group Inc.
NCT06933394 Phase 2
Recruiting
Enrollment
92 pts
Location
China
Sponsor
Sun Yat-Sen Memorial Hospital ...
NCT07399821 Phase 1, Phase 2
Recruiting
Enrollment
22 pts
Location
Netherlands
Sponsor
Princess Maxima Center for Ped...
NCT05400603 Phase 1
Recruiting
Enrollment
24 pts
Location
United States
Sponsor
Emory University
NCT06296732
Recruiting
Enrollment
200 pts
Location
Russia
Sponsor
Federal Research Institute of ...
NCT07584499 Phase 1
Recruiting
Enrollment
51 pts
Location
China
Sponsor
Sun Yat-sen University
NCT01109394
Recruiting
Enrollment
6,035 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT03294954 Phase 1
Recruiting
Enrollment
70 pts
Location
United States
Sponsor
Baylor College of Medicine
NCT06395103 Phase 1, Phase 2
Recruiting
Enrollment
90 pts
Location
United States, Austr...
Sponsor
Merck Sharp & Dohme LLC
Related Conditions
osteosarcoma (2) primitive neuroectodermal tumor (2) rhabdomyosarcoma (2) ewing sarcoma (2) urachal cancer (1) parathyroid carcinoma (1) fibrolamellar carcinoma (1) angiosarcoma (1) secretory carcinoma of breast (1) anal neoplasms (1) metaplastic breast carcinoma (1) translocation renal cell carcinoma (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology